Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,192Revenue (TTM) $M2,253Net Margin (%)18.4Altman Z-Score9.4
Enterprise Value $M21,951EPS (TTM) $2.8Operating Margin %24.8Piotroski F-Score6
P/E(ttm)54.2Beneish M-Score-2.5Pre-tax Margin (%)23.1Higher ROA y-yN
Price/Book11.110-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsY
Price/Sales10.05-y EBITDA Growth Rate %24.8Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow47.6y-y EBITDA Growth Rate %-1.8ROA % (ttm)11.3Higher Current Ratio y-yY
Dividend Yield %--PEG2.2ROE % (ttm)22.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M147ROIC % (ttm)27.4Gross Margin Increase y-yN

Gurus Latest Trades with ILMN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ILMNJulian Robertson 2016-03-31 Sold Out -2.56%$135.37 - $191.95
($157.69)
$ 150.76-4%Sold Out0
ILMNSteve Mandel 2016-03-31 Reduce-1.59%$135.37 - $191.95
($157.69)
$ 150.76-4%Reduce -53.59%1,675,158
ILMNRon Baron 2016-03-31 Reduce-0.16%$135.37 - $191.95
($157.69)
$ 150.76-4%Reduce -12.52%1,228,286
ILMNGeorge Soros 2016-03-31 Sold Out -0.01%$135.37 - $191.95
($157.69)
$ 150.76-4%Sold Out0
ILMNJulian Robertson 2015-12-31 Reduce-1.3%$140.17 - $194.18
($166.62)
$ 150.76-10%Reduce -34.89%103,200
ILMNVanguard Health Care Fund 2015-12-31 Reduce-0.09%$140.17 - $194.18
($166.62)
$ 150.76-10%Reduce -7.86%2,787,466
ILMNRon Baron 2015-12-31 Reduce-0.04%$140.17 - $194.18
($166.62)
$ 150.76-10%Reduce -3.74%1,404,071
ILMNGeorge Soros 2015-12-31 Buy 0.01%$140.17 - $194.18
($166.62)
$ 150.76-10%New holding2,100
ILMNSteve Mandel 2015-09-30 Reduce-1.69%$167.51 - $240.02
($208.03)
$ 150.76-28%Reduce -36.43%3,609,735
ILMNJulian Robertson 2015-09-30 Add0.91%$167.51 - $240.02
($208.03)
$ 150.76-28%Add 32.19%158,500
ILMNVanguard Health Care Fund 2015-09-30 Add0.24%$167.51 - $240.02
($208.03)
$ 150.76-28%Add 26.02%3,025,105
ILMNRon Baron 2015-09-30 Reduce-0.04%$167.51 - $240.02
($208.03)
$ 150.76-28%Reduce -3.35%1,458,569
ILMNSteve Mandel 2015-06-30 Add2.28%$182.21 - $220.75
($200.55)
$ 150.76-25%Add 96.48%5,678,537
ILMNJulian Robertson 2015-06-30 Add0.52%$182.21 - $220.75
($200.55)
$ 150.76-25%Add 16.41%119,900
ILMNRon Baron 2015-06-30 Add0.25%$182.21 - $220.75
($200.55)
$ 150.76-25%Add 23.70%1,509,065
ILMNVanguard Health Care Fund 2015-06-30 Add0.2%$182.21 - $220.75
($200.55)
$ 150.76-25%Add 24.20%2,400,500
ILMNJoel Greenblatt 2015-06-30 Sold Out -0.02%$182.21 - $220.75
($200.55)
$ 150.76-25%Sold Out0
ILMNSteve Mandel 2015-03-31 Buy 2.03%$180.91 - $203.25
($193.62)
$ 150.76-22%New holding2,890,103
ILMNRon Baron 2015-03-31 Reduce-0.13%$180.91 - $203.25
($193.62)
$ 150.76-22%Reduce -13.37%1,219,938
ILMNJoel Greenblatt 2015-03-31 Add0.01%$180.91 - $203.25
($193.62)
$ 150.76-22%Add 79.87%13,069
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ILMN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ILMN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EPSTEIN ROBERT SDirector 2016-07-20Sell1,200$1500.51view
FLATLEY JAY TDirector 2016-07-18Sell10,000$1500.51view
BOWMAN A BLAINEDirector 2016-07-14Sell5,000$147.142.46view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-07-11Sell716$141.896.25view
BOWMAN A BLAINEDirector 2016-06-16Sell5,000$135.0811.61view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-06-15Sell2,141$137.99.33view
WHITFIELD ROY ADirector 2016-06-13Sell3,800$140.447.35view
EASTHAM KARINDirector 2016-06-01Sell5,000$145.353.72view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-05-25Sell2,141$144.734.17view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-05-17Sell2,141$140.847.04view

Press Releases about ILMN :

Quarterly/Annual Reports about ILMN:

News about ILMN:

Articles On GuruFocus.com
Baron Funds Comments on Illumina Inc. Jul 13 2016 
Weekly CEO Sells Highlights Jun 28 2016 
Baron Funds Comments on Illumina Inc. May 23 2016 
Baron Funds Comments on Illumina May 06 2016 
Baron Funds Comments on Illumina Inc. Apr 26 2016 
Should You Wait to Bet on Agilent Technologies? Dec 20 2015 
Julian Robertson Keeps Buying Citigroup, Netflix, Facebook Dec 07 2015 
Halvorsen's Investment Makes Broadcom His Fifth-Most Valuable Stake Dec 05 2015 
Barron Asset Fund Third Quarter Letter - Part One Nov 02 2015 
Baron Funds Comments on Illumina Inc. Nov 02 2015 

More From Other Websites
13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys Jul 21 2016
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards? Jul 19 2016
Baron Funds Comments on Illumina Inc. Jul 13 2016
[$$] David Lee's New Fund Backs Agtech Startup Jul 13 2016
Coverage Initiated on Select Biotech Stocks Jul 13 2016
Exact Sciences (EXAS) Stock Rising on Illumina Takeover Speculation Jul 12 2016
Illumina to Announce Second Quarter 2016 Financial Results on Tuesday, July 26, 2016 Jul 12 2016
[$$] Lawrence Bock, Pioneering Biotech Investor, Dies at 56 Jul 11 2016
Silence the Noise: Illumina Revenue Is Trending Higher Jul 10 2016
Illumina Stock Hit by Downbeat Guidance, Stiff Competition Jul 08 2016
Illumina Applauds FDA’s Issuance of Draft Guidances to Advance Precision Medicine Using Next... Jul 07 2016
Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : July 6, 2016 Jul 06 2016
Illumina Downgraded On Outlook For Cancer, Academic Research Jul 05 2016
Stocks Make Weak Start; Tesla, Illumina Weigh Jul 05 2016
Illumina (ILMN) Stock Slumps on Morgan Stanley Downgrade Jul 05 2016
Morning Movers: Tesla Tanks on Delivery Miss; Rowan Sinks Jul 05 2016
Illumina downgraded by Morgan Stanley Jul 05 2016
Illumina, MolecularMD to Co-Develop Oncology Diagnostics Jun 29 2016
Natera and Illumina Extend Supply Agreement, Broaden Existing Partnership to Include Oncology Field Jun 29 2016
Top money managers take temperature of health stocks: 'Genomics' firms to soar Jun 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)